Acuamark Diagnostics is dedicated to developing technology which allows for blood-based screening and early detection of cancer.
Cancer is now the leading cause of death in developed countries, and the biggest single cause of death worldwide, with 8.2 million deaths in 2012. Cancer cases worldwide are forecasted to rise by 75% and reach close to 25 million over the next two decades. Cancer deaths are expected to rise to 13 million per year. Our mission statement as a company is guided by the realization that the global battle against cancer won’t be won by treatment alone. Effective preventative measures are urgently needed to stem the escalation of cancer cases the world faces.
We are a team of scientists and business people that are unified towards contributing to this global fight. Drawing from our combined experience, we are attacking this problem by developing technology which analyzes blood samples to accurately screen and detect cancer at the earliest possible stage. We are currently on-track to develop an accurate, scalable and economical blood-based screening solution in the near future.